Tony Chen's practice focuses on patent litigation and portfolio management, technology licensing, R&D collaborations, and strategy counseling. He has advised Suzhou BioBay on the development of its biopharmaceutical industry as well as Shanghai Pudong New Area. Between 2010 and 2012, he co-chaired the IP subcommittee of the American Chamber of Commerce in Shanghai.Tony was trained as a molecular biologist before studying law at Harvard University. He practiced patent law in California for more than a decade where he represented a wide range of high-tech and biotech companies in patent litigation, prosecution, and licensing. He also acted as an in-house patent counsel for a leading specialty pharmaceutical company managing patent litigation, IP due diligence, and technology agreements. In addition, he co-founded a drug discovery technology company in Silicon Valley backed by leading venture capital investors from the U.S., Europe, and Asia.